Back to Search

JAYMIN PATEL, D.O.

D.O.

Family Medicine Physician

NPI: 1881048130IndividualAccepts Medicare

Specialties, Licenses & Credentials

Student in an Organized Health Care Education/Training Program

Student in an Organized Health Care Education/Training Program

Code: 390200000X

Family Medicine PhysicianPrimary

Family Medicine

Code: 207Q00000X

02005594A(IN)

CMS Specialties

PrimaryFAMILY PRACTICE

Education

OTHER

Class of 2016

Research & Publications (20)

Genetic engineering of Caulobacter crescentus for removal of cadmium from water.
PMID 19214794·Appl Biochem Biotechnol·2010
8-other
Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy.
PMID 18720199·J Microencapsul·2009
7-preclinical
Transcatheter aortic valve replacement: a potential option for the nonsurgical patient.
PMID 19569066·Clin Cardiol·2009
6-review
Circulating biomarkers of angiogenesis as indicators of left ventricular systolic dysfunction amongst patients with coronary artery disease.
PMID 19187100·J Intern Med·2009
8-other
Treatment rationale and study design for the pointbreak study: a randomized, open-label phase III study of pemetrexed/carboplatin/bevacizumab followed by maintenance pemetrexed/bevacizumab versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
PMID 19632943·Clin Lung Cancer·2009
3-trial
Review of companion animal viral diseases and immunoprophylaxis.
PMID 19041354·Vaccine·2009
6-review
Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release.
PMID 19458227·J Neurosci·2009
7-preclinical
Circulating levels of adiponectin, leptin, and tumour necrosis factor alpha in hypertension.
PMID 19172446·Ann Med·2009
8-other
Diversification of a Salmonella virulence protein function by ubiquitin-dependent differential localization.
PMID 19379694·Cell·2009
8-other
Phase II study of pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer.
PMID 19433684·J Clin Oncol·2009
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
5908 E STOP 11 RD
INDIANAPOLIS, IN 46237

Locations (2)

Practice Location

5908 E STOP 11 RD, INDIANAPOLIS, IN
(317) 497-6800

Practice Location

1011 MAIN ST, INDIANAPOLIS, IN
(317) 957-9050

Quick Facts

NPI
1881048130
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
2
Years in Practice
10
Publications
20

Are you this provider?

Claim Your Profile